Hoertkorn Richard Charles Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.79M |
| 2 |
GSK
GSK
|
+$1.24M |
| 3 |
Wells Fargo
WFC
|
+$1.1M |
| 4 |
IBM
IBM
|
+$1,000K |
| 5 |
Kinder Morgan
KMI
|
+$673K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.07M |
| 2 |
Pfizer
PFE
|
+$473K |
| 3 |
Home Depot
HD
|
+$390K |
| 4 |
Johnson & Johnson
JNJ
|
+$264K |
| 5 |
Boeing
BA
|
+$230K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.16% |
| 2 | Technology | 16.69% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Energy | 11.31% |
| 5 | Industrials | 10.49% |
Similar funds
Hoertkorn Richard Charles's Q4 2016 Portfolio in Review
As of Q4 2016, Hoertkorn Richard Charles held 94 positions worth $145M, up 13% from $128M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Hoertkorn Richard Charles deployed $5.41M of net new capital in Q4 2016, opening 4 new positions and adding to 21 existing holdings. Its largest new stake was Salesforce: 500 shares worth $34K.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Procter & Gamble, an estimated $1.07M trimmed.
- Hoertkorn Richard Charles's largest Q4 2016 buy was Salesforce: 500 shares worth $34K.
- Hoertkorn Richard Charles added most to Citigroup in Q4 2016, an estimated $1.79M increase.
- Hoertkorn Richard Charles's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $1.07M.
- Hoertkorn Richard Charles fully exited Invesco Financial Preferred ETF in Q4 2016, selling an estimated $38K.
- Hoertkorn Richard Charles's ten largest holdings make up 48% of its $145M portfolio in Q4 2016.
- Hoertkorn Richard Charles opened 4 new positions and closed 5 in Q4 2016.
- Hoertkorn Richard Charles's portfolio value rose 13% quarter-over-quarter to $145M.
Based on Hoertkorn Richard Charles's 13F filing for Q4 2016, filed 11 Jan 2017.